News & Insights
Sort By
Client News 14 Results
Client News
|April 1, 2025
AIRNA Announces $155M Series B Co-led by Venrock Healthcare and Forbion Growth
RNA editing company, AIRNA, announces its $155 million Series B financing co-led by Venrock Healthcare Capital Partners and Forbion Growth
Client News
|October 8, 2024
City Therapeutics Announces Launch with $135M Series A Financing
City Therapeutics announces its launch and $135 million Series A financing led by ARCH Ventures
Client News
|September 9, 2024
Vignette Bio Announces its Merger with Candid Therapeutics
Foresite Labs incubated company, Vignette Bio, announces its acquisition by Candid Therapeutics, an innovative biotechnology company developing T-cell engager (“TCE”) antibodies
Firm News 1 result
Firm News
|April 3, 2025
Gunderson Dettmer Wins China Business Law Journal’s 2024 “Deals of the Year”
Gunderson Dettmer has been recognized in China Business Law Journal’s 2024 “Deals of the Year” report for our participation in a standout transaction in the PE/VC category.